Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Minerva Med ; 76(44): 2131-4, 1985 Nov 17.
Artigo em Italiano | MEDLINE | ID: mdl-2999645

RESUMO

A 40 year old woman who took a daily dose of 2-4 mg of Ergotamine Tartrate (Cafergot) regularly for 6 years to combat persistent migraine, was treated for a non-atherosclerotic arterial disease, severe arteriospasm of the great limb arteries, hyperplasia of the intima and segmental thrombosis. Binding of adrenergic alpha and beta receptors was investigated. Surprisingly it was found that the number of adrenergic beta receptors was significantly lower thant that of a healthy woman of the same age used as a control while the number of alpha receptors was not significantly different. This action of ergotamine on beta receptors could be explained by a dopamine-mimetic stimulation, due to the central nervous system, that could lead to the preferential regulation of beta receptors rather than alpha receptors, almost as a protective mechanism of alpha receptors.


Assuntos
Arteriopatias Oclusivas/etiologia , Ergotismo/complicações , Adulto , Ergotamina/efeitos adversos , Ergotamina/uso terapêutico , Feminino , Humanos , Transtornos de Enxaqueca/tratamento farmacológico , Receptores Adrenérgicos alfa/análise , Receptores Adrenérgicos beta/análise , Trombose/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA